We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CVS Health Corporation | NYSE:CVS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-11.15 | -16.47% | 56.56 | 56.885 | 54.00 | 56.00 | 65,768,811 | 00:59:15 |
1. Name and Address of Reporting Person * Roberts Jonathan C | 2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & Chief Operating Officer |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 1/8/2020 | M | 68844 | A | $54.53 | 102607.6311 | D | |||
Common Stock | 1/8/2020 | S(1) | 57563 | D | $72.63 (2) | 45044.6311 | D | |||
Common Stock (restricted) | 41246 | D | ||||||||
ESOP Common Stock | 5772.6789 | I | By ESOP | |||||||
Stock Unit | 230362.6616 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option | $54.53 | 1/8/2020 | M | 68844 | 4/1/2014 (3) | 4/1/2020 | Common Stock | 68844 | $0 | 0 | D | ||||
Phantom Stock Credits | $1.00 | (4) | (4) | Common Stock | 1424.1494 | 1424.1494 | D | ||||||||
Stock Option | $74.29 | 4/1/2015 (5) | 4/1/2021 | Common Stock | 73433 | 73433 | D | ||||||||
Stock Option | $45.93 | 9/4/2015 (6) | 9/4/2022 | Common Stock | 108870 | 108870 | D | ||||||||
Stock Option | $102.26 | 4/1/2016 (7) | 4/1/2022 | Common Stock | 68482 | 68482 | D | ||||||||
Stock Option | $104.82 | 4/1/2017 (8) | 4/1/2023 | Common Stock | 161318 | 161318 | D | ||||||||
Stock Option | $78.05 | 4/3/2018 (9) | 4/3/2024 | Common Stock | 200358 | 200358 | D | ||||||||
Stock Option | $62.21 | 4/1/2019 (10) | 4/1/2025 | Common Stock | 248131 | 248131 | D | ||||||||
Stock Option | $54.19 | 4/1/2020 (11) | 4/1/2029 | Common Stock | 303010 | 303010 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Roberts Jonathan C ONE CVS DRIVE WOONSOCKET, RI 02895- | EVP & Chief Operating Officer |
Signatures | ||
Jonathan C. Roberts | 1/10/2020 | |
**Signature of Reporting Person | Date |
1 Year CVS Health Chart |
1 Month CVS Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions